NeuroSense Therapeutics announced on September 4, 2025, that it secured financing from investors based in Cambridge, Massachusetts.
3 reports, 2 independent
Updated Wed 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NeuroSense Therapeutics announced on September 4, 2025, that it secured financing from investors based in Cambridge, Massachusetts.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Hedge fund Yorkville Advisors bought a new position in NeuroSense Therapeutics stock following its Nasdaq listing.1 source
NeuroSense Therapeutics received financing from investors in Cambridge, MA.1 source
Keep exploring
The entities involved
-
Cambridge
city in Middlesex County, Massachusetts, United States of America
Coverage
Newest first; wire copies grouped- dailypolitical.com
- PR NewswireNeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price Financing at 40% premium to market price provides near-term bridge to anticipated milestones CAMBRIDGE, Mass.,